|
2021 Conference Publication Activation of stimulator of interferon genes in dendritic cells induces interferon-lambda and subset- and species-specific dendritic cell deathPang, Ee Shan, Daraj, Ghazal, Macri, Christophe, Balka, Katherine, de Nardo, Dominic, Hochrein, Hubertus, Masterman, Kelly-Anne, Zhan, Yifan, Kile, Benjamin, Lawlor, Kate, Radford, Kristen, Wright, Mark and O’Keeffe, Meredith (2021). Activation of stimulator of interferon genes in dendritic cells induces interferon-lambda and subset- and species-specific dendritic cell death. Immunology 2021™ Meeting, Online, 10–15 May 2021. Rockville, MD United States: American Association of Immunologists. doi: 10.4049/jimmunol.206.supp.111.28 |
|
2018 Conference Publication Targeting human CD141+DC using CLEC9A antibodies for cancer immunotherapyMasterman, K-A., Pearson, F. E., Tullett, K., Haigh, O., Walpole, C., Daraj, G., Lahoud, M. H., Rojas, I. Leal and Radford, K. (2018). Targeting human CD141+DC using CLEC9A antibodies for cancer immunotherapy. ESMO Immuno-Oncology Congress, Geneva Switzerland, Dec 13-16, 2018. OXFORD: OXFORD UNIV PRESS. |
|
2018 Conference Publication Characterising the effects of interferon lambda on dendritic cell function and activationPang, E. S., Macri, C., Lundie, R., Pooley, J., Gearing, J., Pupovac, A., Jacobson, K., Hertzog, P., Hochrein, H., Radford, K. and O'Keeffe, M. (2018). Characterising the effects of interferon lambda on dendritic cell function and activation. 15th International Symposium on Dendritic Cells (DC), Aachen Germany, Jun 10-14, 2018. HOBOKEN: WILEY. |
|
2018 Conference Publication Targeting human CD141(+) DC using CLEC9A antibodies for cancer immunotherapyPearson, F., Masterman, K. A., Tullett, K., Haigh, O., Walpole, C., Daraj, G., Rojas, Leal, Lahoud, M. H. and Radford, K. (2018). Targeting human CD141(+) DC using CLEC9A antibodies for cancer immunotherapy. 15th International Symposium on Dendritic Cells (DC), Aachen Germany, Jun 10-14, 2018. Hoboken, NJ United States: Wiley. |
|
2016 Conference Publication Human dendritic cell interactions with P-falciparum provide insight into the development of host immunity to malariaYap, X. Z., Lundie, R. J., Macri, C. F., Rojas, Leal, I, Feng, G., Radford, K. J., Beeson, J. G. and O'Keeffe, M. (2016). Human dendritic cell interactions with P-falciparum provide insight into the development of host immunity to malaria. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Conference Publication Characterising the effects of interferon lambda on dendritic cellsPang, E. S., Macri, C., Pooley, J., Fancke, B., Lundie, R., Hochrein, H., Radford, K. and O'Keeffe, M. (2016). Characterising the effects of interferon lambda on dendritic cells. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Conference Publication Targeting CLEC9A can deliver antigen to human CD141(+) DC for recognition by both CD4(+) and CD8(+) T cellsTullett, K. M., Leal Rojas, I. M., Minoda, Y., Tan, P. S., Zhang, J. -G, Smith, C., Khanna, R., Shortman, K., Caminschi, I, Lahoud, M. H. and Radford, K. J. (2016). Targeting CLEC9A can deliver antigen to human CD141(+) DC for recognition by both CD4(+) and CD8(+) T cells. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21-26 August, 2016. Weinheim, Germany: Wiley. |
|
2016 Conference Publication Molecular basis for the efficient processing of antigens taken up by Clec9A, a DAMP receptor on dendritic cellsTan, P. S., Tullett, K., Park, H-Y, Gruber, E., Radford, K., Nicola, N., Zhang, J-G, Shortman, K., Caminschi, I and Lahoud, M. (2016). Molecular basis for the efficient processing of antigens taken up by Clec9A, a DAMP receptor on dendritic cells. International Congress of Immunology (ICI), Melbourne Australia, Aug 21-26, 2016. HOBOKEN: WILEY-BLACKWELL. |
|
2016 Conference Publication Enhanced activation of human CD141(+) DC and CD1c(+) DC in vivo with combined TLR3/TLR8 ligationChang, K., Minoda, Y., Leal Rojas, I, Tullett, K. and Radford, K. (2016). Enhanced activation of human CD141(+) DC and CD1c(+) DC in vivo with combined TLR3/TLR8 ligation. International Congress of Immunology (ICI), Melbourne, VIC, Australia, 21-26 August, 2016. Weinheim, Germany: Wiley. |
|
2015 Conference Publication Mobilization of CD8(+) Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin BlockadeWinkler, Ingrid G., Barbier, Valerie, Radford, Kristen J., Davies, Julie M., Levesque, Jean-Pierre, Smith, Theodore A. G., Fogler, William E. and Magnani, John L. (2015). Mobilization of CD8(+) Central Memory T-Cells with Enhanced Reconstitution Potential in Mice By a Combination of G-CSF and GMI-1271-Mediated E-Selectin Blockade. 57th Annual Meeting of the American Society of Hematology, Orlando, FL United States, 5-8 December 2015. Washington, DC United States: American Society of Hematology. doi: 10.1182/blood.V126.23.512.512 |
|
2011 Conference Publication Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCLGandhi, MK, Hertzberg, MS, Han, E, Seymour, JF, Hicks, R, Gill, DS, Keane, C, Crooks, P, Radford, K and Vari, F (2011). Monocytes Are Associated with Impaired T-Cell Immunity and Residual Interim-PET/CT Avidity After 4 Cycles of CHOP-R In Patients with High-Risk DLBCL. 53rd Annual Meeting and Exposition of the American-Society-of-Hematology (ASH), San Diego Ca, Dec 10-13, 2011. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2009 Conference Publication CD83 antibody prevents GvHD and does not impair GvL inductionCullup, H., Wilson, J., Lourie, R., Shen, Y., Palkova, A., Radford, K., Dickinson, A. M., Rice, A., Hart, D. and Munster, D. (2009). CD83 antibody prevents GvHD and does not impair GvL induction. 35th Annual Meeting of the European-Group-for-Blood-and-Marrow-Transplantation, Goteborg Sweden, Mar 29-Apr 01, 2009. LONDON: NATURE PUBLISHING GROUP. |
|
2007 Conference Publication Residual lymphocytes in GM-CSF and IL-15 differentiated monocyte-derived dendritic cells enables cytotoxic T lymphocyte responsesHardy, Melinda Y., Kassianos, Andrew J., Wilkinson, Ray, Vulink, Anneie, Hart, Derek N. J. and Radford, Kristen J. (2007). Residual lymphocytes in GM-CSF and IL-15 differentiated monocyte-derived dendritic cells enables cytotoxic T lymphocyte responses. 49th Annual Meeting of the American-Society-of-Hematology, Atlanta Ga, Dec 08-11, 2007. WASHINGTON: AMER SOC HEMATOLOGY. |
|
2005 Conference Publication Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cellsHardy, MY, Kassianos, AJ, Clark, GJ, Hart, DNJ and Radford, KJ (2005). Production of IL-2, IL-12, and IL-10 by human blood myeloid dendritic cells. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING. |
|
2005 Conference Publication Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responsesMckinlay, A, Radford, KJ, Gardiner, D, Khalil, D, Field, K, Burnell, F, Hart, DNJ and Vuckovic, S (2005). Human memory CD4(+) T cells maintained in the absence of antigen develop regulatory T cells capable of suppressing antibody responses. 35th Annual SCientific Meeting of the Australasian-Society-for-Immunology/14th International HLA and Immunogenetics Workshops, Melbourne Australia, Nov 29-Dec 02, 2005. OXFORD: BLACKWELL PUBLISHING. |
|
2004 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapyTurtle, C. J., Radford, K. J., Allan, C. P., Kassianos, A., Kato, M., Vuckovic, S., MacDonald, K.J., Lopez, Jose A., Jackson, D. C., Wright, S., Taylor, K., Marlton, P., Gill, D., Hart, D. N. J. and Korngold, R. (2004). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy. Tandem BMT 2004 Meeting, Orlando, Florida, U.S., 13-17 February 2004. CHARLOTTESVILLE: AMER SOC HEMATOLOGY. doi: 10.1016/j.bbmt.2003.12.081 |
|
2003 Conference Publication RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.Turtle, CJ, Radford, KJ, Allan, CP, Kato, M and Hart, DNJ (2003). RNA-loading of CMRF-56 positive blood dendritic cells is a promising strategy for multiple myeloma immunotherapy.. 45th Annual Meeting of the American-Society-of-Hematology, San Diego California, Dec 06-09, 2003. WASHINGTON: AMER SOC HEMATOLOGY. |
